# LEVETIRACETAM IN SODIUM CHLORIDE
> **ANDA218364** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2026-05-08
## Drug
- **FDA Application Number:** ANDA218364
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEVETIRACETAM IN SODIUM CHLORIDE
- **Generic name:** Levetiracetam
- **Active ingredients:** LEVETIRACETAM
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** MYLAN LABS LTD
- **First approval:** 2026-05-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218364)
---
*MORVS · CC0 1.0*